CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.68, no.6, pp.1497-1505, 2011 (SCI-Expanded)
The aim of this study was to evaluate efficacy and feasibility of a combination of weekly docetaxel and cisplatin administered concomitantly with radiotherapy followed by surgery in addition to consolidation chemotherapy with docetaxel and cisplatin administered every 3 weeks in stage III non-small cell lung cancer (NSCLC).